Harrowe
Greg Harrowe, Berkeley, CA US
Patent application number | Description | Published |
---|---|---|
20130196314 | Genes Differentially Expressed in Breast Cancer - A polynucleotide sequence as shown in SEQ ID NO:1 is associated with metastatic potential of cancer cells, especially breast cancer cells. Methods are provided for determining the risk of metastasis of a tumor, by determining whether a tissue sample from a tumor expresses a polypeptide or mRNA encoded by a polynucleotide as shown in SEQ ID NO:1. Also provided are therapeutic methods and compositions. | 08-01-2013 |
Gregory Martin Harrowe, Emeryville, CA US
Patent application number | Description | Published |
---|---|---|
20140093492 | METHOD FOR PREVENTING AND TREATING CANCER METASTASIS AND BONE LOSS ASSOCIATED WITH CANCER METASTASIS - M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal. | 04-03-2014 |
Gregory Martin Harrowe, Eugene, OR US
Patent application number | Description | Published |
---|---|---|
20140242071 | M-CSF SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF - M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease. | 08-28-2014 |